Citadel Advisors
NSPR icon

Citadel Advisors’s InspireMD NSPR Stock Holding History

Citadel Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,500
Closed -$28.8K – 15042
2024
Q1 		$28.8K Buy
+12,500
New +$33.7K ﹤0.01% 12730
2023
Q1 		– Sell
-600
Closed -$516 – 15239
2022
Q4 		$516 Buy
+600
New +$675 ﹤0.01% 14636
2022
Q1 		– Sell
-12,200
Closed -$37K – 14260
2021
Q4 		$37K Sell
12,200
-6,800
-36% -$25.5K ﹤0.01% 13400
2021
Q3 		$78K Buy
+19,000
New +$80.6K ﹤0.01% 13089

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Citadel Advisors's NSPR Position: Q1 2026 in Review

Citadel Advisors reduced its InspireMD (NSPR) stake by 66% in Q1 2026, selling an estimated $218K and leaving 65,750 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #11953.

Citadel Advisors first reported a position in NSPR in Q1 2018 and has held it in 13 quarters since. The position peaked at $345K in Q4 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Citadel Advisors held 65,750 shares of InspireMD worth $107K as of Q1 2026.
  • Citadel Advisors sold 127,960 InspireMD shares in Q1 2026, an estimated $218K.
  • InspireMD made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11953 holding.
  • Citadel Advisors first reported a position in InspireMD in Q1 2018 and has held it in 13 quarters since.
  • Citadel Advisors's InspireMD position peaked at $345K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.